News

New Approach to Cancer Immunotherapy Improves Efficacy and Decreases Toxicity College of Science Newsletter, University of Notre Dame (July 9, 2026).

https://chemistry.nd.edu/news/new-approach-to-cancer-immunotherapy-improves-efficacy-and-decreases-toxicity/

Researchers to Watch in Women’s Health World of Women’s Health, LinkedIn (June 16, 2026).

https://www.linkedin.com/feed/update/urn:li:share:7470158918221066242/

Endometriosis Diagnosis—Reimagined. (April 26, 2026). In collaboration with InterVenn biosciences. All rights reserved.

Our vision

Our initial analysis is in!

Expanding endometriosis research: Postdoctoral researcher Ell Handy focuses on women’s health (April 21, 2025).

https://science.nd.edu/news-and-media/news/expanding-endometriosis-research-postdoctoral-researcher-ell-handy-focuses-on-womens-health/

Unexpected PLOD1 twist Perlara’s Cure Odysseys (2024, January 30).

https://perlara.substack.com/p/unexpected-plod1-twist (credited as L Handy)

The PLOD1 thickens. Perlara’s Cure Odysseys.(2023, April 19).

https://perlara.substack.com/p/the-plod1-thickens(credited as L Handy)

PLOD1-kEDS Cure Roadmap. Perlara’s Cure Odysseys. (2022, June 17).

https://perlara.substack.com/p/plod1-keds-cure-roadmap(credited as L Handy)

Publications

Tumor Immune Cell Targeting Chimeras (TICTACs) reprogram tumor-associated macrophages, Nature Chemical Biology (July 8, 2026)

https://www.nature.com/articles/s41589-026-02258-2

https://www.biorxiv.org/content/10.1101/2023.12.06.570444v2

Synthesis of Biologically Active, Selectively Diversified Iminosugars as Single Enantiomers from 2,4-diene-ols

manuscript under preparation